期刊文献+

对房室吸收和转运模型的修正

Modification of Compartmental Absorption and Transit (CAT) Model
下载PDF
导出
摘要 目的对传统的房室吸收和转运(CAT)模型进行修正,拓宽了CAT模型的适用范围。方法参考CAT模型建立的方法,利用严格的数学推导,并在结合文献数据的基础上,对传统CAT模型进行修正。结果推导得到一个更为合适的CAT模型表达式并尝试建立了一个适用于大鼠的CAT模型,确定了大鼠CAT模型的房室数目为5个。结论修正后的CAT模型适用范围有所拓宽,而大鼠CAT模型更符合大鼠自身的一些生理学特征。 OBJECTIVE To modify the compartmental absorption and transit (CAT) model for extended application. METHODS By referring to some literature data,the traditional CAT model was modified by mathematical decluction and the optimal compartment number of a new CAT model was determined for rat. RESULTS A more general equation of CAT model was derived, and a five compartment CAT model was used for rat. CONCLUSION The modified CAT model was applicable and the new CAT model with five compartments is consistent with the physiological feature of rat.
出处 《中国药学杂志》 CAS CSCD 北大核心 2008年第15期1180-1184,共5页 Chinese Pharmaceutical Journal
关键词 房室吸收和转运模型 模型修正 拉普拉斯变换 compartmental absorption and transit (CAT) model modification to the model laplace transform
  • 相关文献

参考文献21

  • 1卢韵,姚静,周建平.基于流体传质理论的肠吸收模型[J].药学进展,2006,30(5):200-205. 被引量:1
  • 2YU L X, LIPKA E, CRISON J R, et al. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption [ J ]. Adv Drug Deliv Rev, 1996,19 (3) : 359-376.
  • 3FAGERHOLM U,JOHANSSON M,LENNERNAS H. Comparison between permeability coefficients in rat and human jejunum [ J ]. Pharm Res, 1996,13 ( 9 ) : 1336-1342.
  • 4LENNERNAS H, AHRENTEDT O, HALLGREN R,et al. Regional jejunal perfusion, a new in vivo approach to study oral drug absorption in man[J]. Pharm Res,1992,9(10) : 1243-1251.
  • 5YU L X,CRISON J R,AMIDON G L. Compartmental transit and dispersion model analysis of small intestinal transit flow in humans[J],Int J Pharm,1996,140( 1 ) : 111-118.
  • 6YU L X,AMIDON G L. A compartmental absorption and transit model for estimating oral drug absorption [ J ]. Int J Pharm, 1999,156(2) : 119-125.
  • 7YU L X ,AMIDON G L. Saturable small intestinal drug absorption in humans : modeling and interpretation of cefatrizine data [ J ]. Eur J Pharm Biopharm,1998,45( 2 ) : 199-203.
  • 8PING Q N.Modern Pharmaceutics(现代药剂学)[M].Beijing:Chinese Medicine Science and Technology Publishing Press,1998:608.
  • 9YU L X, AMIDON G L. Characterization of small intestinal transit time distribution in humans [ J ]. Int J Pharm, 1998,171 (2) : 157-163.
  • 10KARARLI T T. Comparison of the gastrointestinal anatomy ,physiology, and biochemistry of humans and commonly used laboratory animals[ J]. Biopharm Drug Dispos, 1995,16 : 351-3$0.

二级参考文献23

  • 1游剑,李青坡,于英伟,崔福德.运用单向灌流模型研究莪术油中三成分对大鼠在体肠的吸收[J].药学学报,2004,39(10):849-853. 被引量:31
  • 2Parrott N, Lave T. Prediction of intestinal absorption:comparative assessment of GASTROPLUS and IDEA[J]. Eur J Pharm Sci, 2002, 17(1-2):51-61.
  • 3Amidon G L, Lennernas H, Shah V P, et al. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability[J]. Pharm Res, 1995, 12(3):413-420.
  • 4Sinko P J, Leesman G D, Amidon G L. Predicting fraction dose absorbed in humans using a macroscopic mass balance approach[J]. Pharm Res, 1991, 8(8):979-988.
  • 5Amidon G L, Kou J, Elliott R L, et al. Analysis of models for determining intestinal wall permeabilities [J]. J Pharm Sci, 1980, 69(12) : 1369-1373.
  • 6Yokokawa M, Nishigaki R, Umemura K, et al. Intestinal absorption kinetics using a laminar flow model [J]. J Pharmacobiodyn, 1989, 12(6):332-340.
  • 7Ni P F, Ho N F, Fox J L, et al. Theoretical model studies of intestinal drug absorption V. non-steady-state fluid flow and absorption[J]. Int J Pharm, 1980, 5(1):33-47.
  • 8陈晋南.传质过程原理[M].北京:化学工业出版社,2003.
  • 9Fagerholm U, Johansson M, Lennernas H. Comparison between permeability coefficients in rat and human jejunum[J]. Pharm Res, 1996, 13(9):1336-1342.
  • 10柯斯乐.流体系统中的传质[M].王宇新,姜忠义译.2版.北京:化学工业出版社,2002.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部